Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4069497
Max Phase: Preclinical
Molecular Formula: C23H20N2O2
Molecular Weight: 356.43
Molecule Type: Small molecule
Associated Items:
ID: ALA4069497
Max Phase: Preclinical
Molecular Formula: C23H20N2O2
Molecular Weight: 356.43
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(-c2c(-c3ccc(C)cc3)[nH]c3ccc(N)cc3c2=O)cc1
Standard InChI: InChI=1S/C23H20N2O2/c1-14-3-5-16(6-4-14)22-21(15-7-10-18(27-2)11-8-15)23(26)19-13-17(24)9-12-20(19)25-22/h3-13H,24H2,1-2H3,(H,25,26)
Standard InChI Key: ATFHABKUSCTSBE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 356.43 | Molecular Weight (Monoisotopic): 356.1525 | AlogP: 4.76 | #Rotatable Bonds: 3 |
Polar Surface Area: 68.11 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.19 | CX Basic pKa: 3.58 | CX LogP: 4.44 | CX LogD: 4.44 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.52 | Np Likeness Score: -0.25 |
1. Miliutina M, Ejaz SA, Khan SU, Iaroshenko VO, Villinger A, Iqbal J, Langer P.. (2017) Synthesis, alkaline phosphatase inhibition studies and molecular docking of novel derivatives of 4-quinolones., 126 [PMID:27907877] [10.1016/j.ejmech.2016.11.036] |
Source(1):